NCT00701402已完成不适用
Survey on Time to Lipid-lowering Drug Implementation on Dyslipidemic Patients in General Practice.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 3,655
- 试验地点
- 1
- 主要终点
- time to lipid-lowering drug implementation (immediately, treatment within a period 0-3 month and > 3 month, according to the cardiovascular risk level, (0 risk factor, 1 risk factor, 2 risk factors, ≥ 3 risk factors, secondary prevention).
研究概览
简要总结
The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of dyslipemia made less than 2 years
- •Treated by a lipid-lowering drug
- •Agree to take part in the survey
排除标准
- •Patient included in a clinical trial
结局指标
主要结局
time to lipid-lowering drug implementation (immediately, treatment within a period 0-3 month and > 3 month, according to the cardiovascular risk level, (0 risk factor, 1 risk factor, 2 risk factors, ≥ 3 risk factors, secondary prevention).
时间窗: Once
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
终止
不适用
Tracking of Lipid Lowering Therapy in JordanDyslipidemiasAtherosclerotic Cardiovascular DiseaseNCT05629767Jordan Collaborating Cardiology Group1,000
终止
2 期
Efficacy of Lapaquistat Acetate in Subjects With HypercholesterolemiaHypercholesterolemiaNCT00865228Takeda224
招募中
4 期
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMIMyocardial Infarction, AcuteMyocardial StrainArterial StiffnessQuality of LifeNCT04347434Penza State University300
已完成
不适用
Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisNCT02306590University of Ulm207
已完成
不适用
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)HypercholesterolemiaCoronary Heart DiseaseNCT00730132Organon and Co712